The HELlenic Thoracic Society Initiative for CΟPD and CVD
Recruiting · NCT06595784 · Observational (researchers observe without assigning treatment) · Lead sponsor: Hellenic Thoracic Society
View the official record on ClinicalTrials.gov →What this trial is about
COPD is one of the most common respiratory diseases in Greece, and maybe more than half a million Greek citizens suffer both from COPD and CVD, however their characteristics and management remain unknown. HELICOPD is a national, multicenter, prospective, non-interventional study designed to contribute to better understanding and depicting the demographic and clinical characteristics of this population, the COPD- and CVD-related adverse events in a two-years period, their quality of life and the healthcare resources use. The study is initiated and coordinated by the Hellenic Thoracic Society.
Who can take part
Age range
35 Years to 99 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patients should cumulatively meet the following three (3) criteria to be enrolled in the study:
- To have been diagnosed with chronic obstructive pulmonary disease and at least one cardiovascular comorbidity (heart failure, atherosclerotic cardiovascular disease, atrial Fibrillation, severe valvular disease)
- Adults aged \>35 years at the time of inclusion in the study,
- With signed informed consent for their participation in the study.
Exclusion criteria
- Patients with the below limitations are not eligible to participate in the study
- Patients:
- Without at least one cardiovascular comorbidity,
- With history of lung cancer
- With any other active malignancy and undergoing treatment (chemotherapy/radiotherapy/immunotherapy)
- With any thoracic or abdominal surgery planned during study follow-up period
- With participation in any COPD-related interventional study at study entry or during study duration.
- Without signed informed consent for their participation in the study.
Where it is running
2 locations listed.
- Department of Respiratory Medicine, Medical School, Democritus University of Thrace, University General Hospital - Alexandroupoli, Greece
- 5th Pulmonary Department, "Sotiria" Chest Diseases Hospital, Athens, Greece - Athens, Greece